Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

AstraZeneca's Enhertu wins first EU tumour-agnostic approval for HER2

29th Jun 2026 08:38

(Alliance News) - AstraZeneca PLC on Monday said the European Commission has approved Enhertu as the first tumour-agnostic HER2-directed therapy and antibody drug conjugate in the EU for previously treated patients with HER2-positive metastatic solid tumours. Read More

LONDON BRIEFING: BT, Verizon merge international arms in joint venture

29th Jun 2026 07:57

(Alliance News) - BT and Verizon form international joint venture, Foresight increases its dividend while Plus500 adds to its US prediction markets offering with sports event-based contracts. Read More

AstraZeneca's, Daiichi's Datroway recommended for further EU approval

26th Jun 2026 12:32

(Alliance News) - AstraZeneca PLC on Friday said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of Datroway for a form of breast cancer. Read More

LONDON MARKET CLOSE: Miners peg back FTSE 100 while mid-caps struggle

23rd Jun 2026 16:59

(Alliance News) - The FTSE 100 edged lower on Tuesday held back by weak miners, while fresh US tech falls and soft UK economic data added to the muted mood. Read More

WINNERS & LOSERS: Telecom Plus cuts dividend, warns on profit

23rd Jun 2026 09:58

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

WINNERS & LOSERS: Broker downgrade hits Admiral; PPHE bid collapses

19th Jun 2026 09:38

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday. Read More

AstraZeneca's Ultomiris wins US FDA priority review in kidney disease

15th Jun 2026 08:19

(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologics licence application for Ultomiris as a treatment for adults with immunoglobulin A nephropathy. Read More

AstraZeneca says Truqap combination approved in US for prostate cancer

12th Jun 2026 21:37

(Alliance News) - AstraZeneca PLC on Friday said a Truqap combination has been approved by the US Food & Drug Administration as a first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer. Read More

LONDON MARKET CLOSE: FTSE soars on peace hope as SpaceX IPO blasts off

12th Jun 2026 17:07

(Alliance News) - The FTSE 100 ended the week on the front foot as Iran claimed a deal with the US has "never been closer", while investors were glued to dealing screens as trading in SpaceX kicked off. Read More

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

9th Jun 2026 10:34

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

AstraZeneca progresses elecoglipron after positive phase IIb results

9th Jun 2026 08:09

(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

7th Jun 2026 16:01

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris. Read More

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

6th Jun 2026 09:11

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, Chief Executive Officer Pascal Soriot told the Financial Times in an interview published on Saturday. Read More

LONDON MARKET CLOSE: FTSE 100 edges up while US jobs data lifts dollar

5th Jun 2026 17:05

(Alliance News) - The FTSE 100 clung on to modest gains on Friday despite weak mining stocks, but Wall Street headed south after stronger-than-expected jobs data increased chances of a rate hike across the pond. Read More

Worldwide Healthcare Trust outperforms benchmark; praises AstraZeneca

5th Jun 2026 10:06

(Alliance News) - Worldwide Healthcare Trust PLC on Friday said pharma company AstraZeneca PLC was its top contributor to its portfolio performance while surgical equipment firm Stryker Corp was the top detractor. Read More

AstraZeneca breast cancer drug camizestrant shows "sustained" benefit

2nd Jun 2026 13:55

(Alliance News) - AstraZeneca PLC on Tuesday reported encouraging test results for its breast cancer treatment camizestrant. Read More

BSF Enterprise shares jump on paper in praise of "T-rex leather"

2nd Jun 2026 12:02

(Alliance News) - BSF Enterprise on Tuesday saw its shares rise after the publication of a paper on one of its subsidiaries' synthetic leather products. Read More

AstraZeneca hails Imfinzi and Imjudo liver cancer trial results

1st Jun 2026 13:54

(Alliance News) - AstraZeneca PLC on Monday posted positive phase-three trial results for a combination of its drugs Imfinzi and Imjudo to treat a form of liver cancer. Read More

EARNINGS: Polar Capital Global Healthcare lags benchmark index

29th May 2026 16:42

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

12345678910
FTSE 100 Latest
Value10,484.22
Change-23.80